Poseida Therapeutics
Huang Lijun has accumulated extensive experience in the biotech industry, starting as a POST DOC at the University of Toledo in 2003. They then progressed to roles as a Scientist at Affymetrix, Lead Scientist at Anatrace, Senior Scientist at Aim Biosciense, and Principal Scientist at Hongene Biotech Corporation USA. Currently, they hold the position of Principal Scientist at Poseida Therapeutics, Inc., focusing on developing therapeutics for patients with high unmet medical needs.
Huang Lijun earned a Doctor of Philosophy (Ph.D.) degree from Peking University in Nucleic Acid Chemistry and Medicinal Chemistry from 1998 to 2001. Huang Lijun also attended The University of Toledo, but the specific degree and field of study are unknown.
Poseida Therapeutics
Poseida Therapeutics is a clinical-stage biotechnology company translating best-in-class technology into life-saving cell and gene therapies for patients with high unmet medical needs.